Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells
about
Adverse effect of high glucose concentration on stem cell therapyClinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-AnalysisStem cell therapy to cure type 1 diabetes: from hype to hope.Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 DiabetesCurrent stem cell based therapies in diabetesCurrent progress of human trials using stem cell therapy as a treatment for diabetes mellitusAutografting of bone marrow mesenchymal stem cells alleviates streptozotocin‑induced diabetes in miniature pigs: real-time tracing with MRI in vivo.Macrophages and fibroblasts during inflammation and tissue repair in models of organ regeneration.Human limbal fibroblast-like stem cells induce immune-tolerance in autoreactive T lymphocytes from female patients with Hashimoto's thyroiditis.Benefits of healthy adipose tissue in the treatment of diabetes.Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.Stem cell educator therapy and induction of immune balance.Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trialSystemic transplantation of human umbilical cord derived mesenchymal stem cells-educated T regulatory cells improved the impaired cognition in AβPPswe/PS1dE9 transgenic mice.Hair regrowth in alopecia areata patients following Stem Cell Educator therapy.Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.The American Diabetes Association diabetes research perspective.Autologous cord blood harvesting in North Eastern Italy: ethical questions and emerging hopes for curing diabetes and celiac disease.Association between local neuroretinal function and control of adolescent type 1 diabetes.Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy.Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.Factors determining insulin requirements in women with type 1 diabetes mellitus during pregnancy: a reviewEarly immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary resultsInfusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe DiabetesMild hyperglycemia triggered islet function recovery in streptozotocin-induced insulin-deficient diabetic rats.Mesenchymal Stem and Progenitor Cells in Regeneration: Tissue Specificity and Regenerative Potential.CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?Adipose tissue, hormones, and treatment of type 1 diabetes.Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.The potential of cell-based therapy for diabetes and diabetes-related vascular complications.Unmet needs in autoimmunity and potential new tools.Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review.Fetal stem cells and skeletal muscle regeneration: a therapeutic approach.Cell-based therapy approaches: the hope for incurable diseases.Imaging of complications from hematopoietic stem cell transplantTherapeutic potential of umbilical cord blood cells for type 1 diabetes mellitus.In pursuit of excellence in diabetes care: trends in insulin delivery.Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases.
P2860
Q24609292-1926B27B-7349-42D9-BC27-E72A1002D495Q26748676-8CED93AB-84BB-491B-B724-84C904FF8BC3Q26823294-5B921CE7-BDC7-4B9C-AF1E-0755820F4742Q28071490-5333264D-7A4D-4849-86BF-C57454BD1184Q28074914-200F4361-C01C-4274-A78B-C8EF324C70A2Q28078407-28FC7EB3-E53C-449A-816C-54561A97527CQ33747741-6BF331F9-8319-4A0D-971F-8A552C1ECB45Q33793909-A5CCE40C-A744-49CB-9054-002171C3B582Q33868555-A11D54CB-B3D7-4F8A-8526-A45EAF963BC0Q34023537-AA8C8666-40CA-4F96-8A06-1C7C8985D774Q34201551-88AEAF38-C0F4-4DED-8B80-5163AE32F05FQ34290347-036D9159-9E0D-4283-B758-4CE629DD1315Q34803585-CD66DC04-648F-4601-8329-7A312634503DQ34919216-1D8E73AF-5482-4E39-BC2D-1D782FE4E2CDQ35562516-5024E15F-B71B-43B8-B7F7-B4EBABF6F3E3Q35893795-CA601390-EC52-43D6-A8C9-7B10865E760BQ35976421-EC5657AF-DCB9-4A07-9652-838036618640Q36093081-C069EF53-B6CA-4935-9C1E-401987B7FEF9Q36318300-90BDF5BE-9570-43E9-BEFC-422E96080151Q36437615-8FBDD1D6-FA32-4BAE-9766-497F074BC8AAQ36444328-90CD1A0C-D916-4D83-9AEB-091E89222F44Q37006155-2908F3C1-4E45-4B9A-852F-88AE9B18668AQ37070253-4C5313F9-8DEE-4DC7-8EA9-19AFC367A740Q37255164-6F8554E3-08F5-4F1E-9556-E3E6549BEF58Q37460214-4ECE5749-FBD5-4A4C-9D4E-531135CC7923Q37567757-A0DE24C2-DBC8-4668-86C6-C69DF324E0F8Q37668908-F032F7E1-A851-4E31-8874-027706674D09Q37692502-346E0D32-2C6F-4238-B692-0A2F3A3B6621Q38027744-4500C52A-B9BA-4F26-9C20-A53BA0941DAAQ38071420-473144EA-37E5-46F8-BCBD-4FC4B90EC849Q38135862-AB154793-D662-4D6D-828C-B7BEB94B0553Q38181982-1AD9108A-7525-400E-96AF-76C4483A0105Q38193368-30CEC305-0B54-49DE-A7DB-F321D0E5DB5AQ38236300-3FBE3D98-051C-40E3-BC4C-005C4CCCA6DAQ38249175-0565EE04-4764-49B4-B852-BE5DB2AE052BQ38265206-A7A39100-CB3E-4CE1-AE95-A3DDFA87C964Q38285644-14254370-7EEA-4630-AC84-2C870C797469Q38387552-67754824-A4EA-4AF3-8401-675DD714E331Q39572372-6D43DCC6-856F-4C17-A267-C026461A0C2DQ42176525-0B22C2A3-FF38-428C-8F40-5AAB5A2D62D0
P2860
Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@ast
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@en
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@en-gb
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@nl
type
label
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@ast
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@en
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@en-gb
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@nl
prefLabel
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@ast
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@en
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@en-gb
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@nl
P2093
P2860
P3181
P356
P1433
P1476
Reversal of type 1 diabetes vi ...... derived multipotent stem cells
@en
P2093
Bellur Prabhakar
Chengjin Hu
Mark Holterman
Mary Beth Fisk
Mingliang Ye
Randal Skidgel
Theodore Mazzone
Tingbao Zhao
Xiaoming Sun
P2860
P2888
P3181
P356
10.1186/1741-7015-10-3
P407
P577
2012-01-01T00:00:00Z
P5875
P6179
1049280159